title: Urinary thromboxane and 6-keto-prostaglandin F1 alpha are early markers of acute rejection in experimental pancreas transplantation.
authors.affiliation: Transplant/Urology Laboratories, Royal Hallamshire Hospital, Sheffield, UK.
authors.forename: B F
authors.initials: BF
authors.lastname: Johnson
authors.forename: K N
authors.initials: KN
authors.lastname: Wiley
authors.forename: M
authors.initials: M
authors.lastname: Greaves
authors.forename: F E
authors.initials: FE
authors.lastname: Preston
authors.forename: M
authors.initials: M
authors.lastname: Fox
authors.forename: A T
authors.initials: AT
authors.lastname: Raftery
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000652:urine*; D000681:Amylases / Q000652:urine; D000818:Animals; D015415:Biomarkers; D001786:Blood Glucose / Q000032:analysis; D016572:Cyclosporine / Q000008:administration & dosage; D003921:Diabetes Mellitus, Experimental / Q000652:urine; D006084:Graft Rejection / Q000652:urine*; D016035:Pancreas Transplantation; D011863:Radioimmunoassay; D051381:Rats; D013929:Thromboxane B2 / Q000652:urine*; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D016572:Cyclosporine; D000681:Amylases